China
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.84 B
|
Dec. 31, 2023 | USD 0.25 | NA |
|
China |
|
2 |
USD 848.14 M
|
Dec. 31, 2023 | USD 1.35 | NA |
|
China |
|
3 |
USD 586.79 M
|
Dec. 31, 2023 | USD 0.57 | NA |
|
China |
|
4 |
USD 511.00 M
|
Dec. 31, 2023 | USD 1.34 | NA |
|
China |
|
5 |
USD 487.02 M
|
Dec. 31, 2023 | USD 7.68 | NA |
|
China |
|
6 |
USD 476.61 M
|
Dec. 31, 2023 | USD 0.80 | NA |
|
China |
|
7 |
USD 440.83 M
|
Dec. 31, 2023 | USD 1.44 | NA |
|
China |
|
8 |
USD 393.30 M
|
Dec. 31, 2023 | USD 1.98 | NA |
|
China |
|
9 |
USD 390.02 M
|
Dec. 31, 2023 | USD 0.45 | NA |
|
China |
|
10 |
USD 352.24 M
|
Dec. 31, 2023 | USD 0.41 | NA |
|
China |
|
11 |
USD 313.93 M
|
Dec. 31, 2023 | USD 0.50 | NA |
|
China |
|
12 |
USD 308.60 M
|
Dec. 31, 2023 | USD 3.40 | NA |
|
China |
|
13 |
USD 295.07 M
|
Dec. 31, 2023 | USD 0.87 | NA |
|
China |
|
14 |
USD 253.31 M
|
Dec. 31, 2023 | USD 1.31 | NA |
|
China |
|
15 |
USD 223.09 M
|
Dec. 31, 2023 | USD 1.45 | NA |
|
China |
|
16 |
USD 210.65 M
|
Dec. 31, 2023 | USD 4.49 | NA |
|
China |
|
17 |
USD 206.49 M
|
Dec. 31, 2023 | USD 3.69 | NA |
|
China |
|
18 |
USD 161.88 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
China |
|
19 |
USD 153.31 M
|
Dec. 31, 2023 | USD 3.70 | NA |
|
China |
|
20 |
USD 152.31 M
|
Dec. 31, 2023 | USD 0.97 | NA |
|
China |
|
21 |
USD 150.79 M
|
Dec. 31, 2023 | USD 1.56 | NA |
|
China |
|
22 |
USD 150.06 M
|
Dec. 31, 2023 | USD 2.15 | NA |
|
China |
|
23 |
USD 139.39 M
|
Dec. 31, 2023 | USD 1.54 | NA |
|
China |
|
24 |
USD 134.29 M
|
Dec. 31, 2023 | USD 1.76 | NA |
|
China |
|
25 |
USD 129.67 M
|
Dec. 31, 2023 | USD 0.78 | NA |
|
China |
|
26 |
USD 121.07 M
|
Dec. 31, 2023 | USD 1.73 | NA |
|
China |
|
27 |
USD 115.31 M
|
Dec. 31, 2023 | USD 2.25 | NA |
|
China |
|
28 |
USD 113.49 M
|
Dec. 31, 2023 | USD 1.32 | NA |
|
China |
|
29 |
USD 108.53 M
|
Dec. 31, 2023 | USD 0.75 | NA |
|
China |
|
30 |
USD 90.77 M
|
Dec. 31, 2023 | USD 0.73 | NA |
|
China |
|
31 |
USD 90.09 M
|
Dec. 31, 2023 | USD 3.32 | NA |
|
China |
|
32 |
USD 83.95 M
|
Dec. 31, 2023 | USD 0.37 | NA |
|
China |
|
33 |
USD 81.96 M
|
Dec. 31, 2023 | USD 3.88 | NA |
|
China |
|
34 |
USD 79.60 M
|
Dec. 31, 2023 | USD 3.68 | NA |
|
China |
|
35 |
USD 70.72 M
|
Dec. 31, 2023 | USD 5.28 | NA |
|
China |
|
36 |
USD 68.03 M
|
Dec. 31, 2023 | USD 1.02 | -3.77% |
|
China |
|
37 |
USD 66.88 M
|
Dec. 31, 2023 | USD 2.85 | NA |
|
China |
|
38 |
USD 63.44 M
|
Dec. 31, 2023 | USD 0.75 | NA |
|
China |
|
39 |
USD 63.34 M
|
Dec. 31, 2023 | USD 1.33 | NA |
|
China |
|
40 |
USD 62.87 M
|
Dec. 31, 2023 | USD 0.51 | NA |
|
China |
|
41 |
USD 62.84 M
|
Dec. 31, 2023 | USD 2.45 | NA |
|
China |
|
42 |
USD 60.74 M
|
Dec. 31, 2023 | USD 2.15 | NA |
|
China |
|
43 |
USD 54.17 M
|
Dec. 31, 2023 | USD 6.71 | NA |
|
China |
|
44 |
USD 53.73 M
|
Dec. 31, 2023 | USD 2.28 | NA |
|
China |
|
45 |
USD 53.13 M
|
Dec. 31, 2023 | USD 0.91 | NA |
|
China |
|
46 |
USD 50.27 M
|
Dec. 31, 2023 | USD 0.24 | 0.51% |
|
China |
|
47 |
USD 49.98 M
|
Dec. 31, 2023 | USD 0.30 | NA |
|
China |
|
48 |
USD 44.72 M
|
Dec. 31, 2023 | USD 0.45 | NA |
|
China |
|
49 |
USD 43.94 M
|
Dec. 31, 2023 | USD 5.36 | NA |
|
China |
|
50 |
USD 43.83 M
|
Dec. 31, 2023 | USD 0.38 | NA |
|
China |
The Vaccines company in China with the highest Total Non-Current Liabilities is Inner Mongolia Baotou Steel Union Co., Ltd. (Shanghai Stock Exchange: 600010.SS) at USD 2.84 B.
The Vaccines company in China with the lowest Total Non-Current Liabilities is Changchun BCHT Biotechnology Co. (Shanghai Stock Exchange: 688276.SS) at USD 162.54 K.
The top 10 Vaccines companies in China by Total Non-Current Liabilities are Inner Mongolia Baotou Steel Union Co., Ltd., Genscript Biotech Corporation, Beijing Dabeinong Technology Group Co.,Ltd., Liaoning Cheng Da Co., Ltd., Akeso, Inc., 3SBio Inc., Dian Diagnostics Group Co.,Ltd., Shenzhen Kangtai Biological Products Co., Ltd., Fujian Aonong Biological Technology Group Incorporation Limited and Tech-Bank Food Co., Ltd..
The bottom 10 Vaccines companies in China by Total Non-Current Liabilities are Changchun BCHT Biotechnology Co., HOB Biotech Group Corp.,Ltd, Connect Biopharma Holdings Limited, Burning Rock Biotech Limited, Ascletis Pharma Inc., ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai Shen Lian Biomedical Corporation, Tellgen Corporation, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. and Chengdu Kanghua Biological Products Co., Ltd..